We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

CT Scans Beats Genetics at Predicting Heart Attack Risk

By MedImaging International staff writers
Posted on 24 May 2023
Print article
Image: CT scan is best at predicting heart disease risk in middle age (Photo courtesy of Freepik)
Image: CT scan is best at predicting heart disease risk in middle age (Photo courtesy of Freepik)

Traditionally, doctors have relied on standard risk-factor levels, such as blood pressure and cholesterol, to assess an individual's likelihood of developing coronary heart disease or heart artery blockages. However, these conventional methods can fail to identify some people at risk of heart attacks or other heart-related conditions. Given the hereditary nature of heart disease, scientists have been hopeful that a person's genetics could provide insight into who is most at risk. The concept of polygenic risk scores - a compilation of over 6 million common genetic variants associated with heart disease - was seen as a potential leap forward for personalized medicine. A recent study, however, has found that CT scans are more accurate than genetics in predicting a middle-aged person’s risk for heart disease, such as a heart attack.

In the study, researchers at Northwestern University (Evanston, IL, USA) directly compared the efficacy of genetics and CT scans for coronary artery calcium and demonstrated that the CT scan is superior to genetics at predicting heart disease risk in middle-aged individuals. The study incorporated data from 3,208 adults across two cohorts - one in the U.S. and the other in Rotterdam, Netherlands. This data included risk factors for heart disease (such as smoking status, cholesterol levels, and blood pressure), genetic information, and CT scan data to estimate the risk of developing heart disease over a follow-up period of up to 17 years.

The researchers examined how using either CT scans or polygenic risk scores altered the predicted risk of individuals based on conventional risk factors such as blood pressure and cholesterol. They investigated whether adding either of these markers (CT or genetics) shifted individuals into a different risk category. A low risk individual is defined as someone with less than a 7.5% risk of developing heart disease in the next decade. Those with a risk above 7.5% are typically recommended statins. The study found that genetic data did not affect a person’s risk category based on their conventional risk factors. However, when CT scan data was considered, half the study participants were reclassified into the high-risk group.

“Finding the best way to identify who is at risk for developing heart disease can help determine what needs to be done to lower their risk,” said lead study author Dr. Sadiya Khan, an assistant professor of medicine and preventive medicine at Northwestern University Feinberg School of Medicine and a Northwestern Medicine cardiologist. “This finding can help doctors and patients in managing risk for heart disease, which is the leading cause of death in the U.S.”

“These findings support recommendations to consider CT screening to calculate risk for heart disease in middle-aged patients when their degree of risk is uncertain or in the intermediate range,” Khan said. “The data from the CT scan can help identify individuals who may benefit from medications, such as statins, to reduce their risk of heart disease.”

Related Links:
Northwestern University 

Gold Supplier
Ultrasound Phantom
Multi-Purpose Multi-Tissue Ultrasound Phantom - Model 040GSE
New
Ophthalmological AB Mode Ultrasound Scanner
ODU5
New
Flat Panel Detector (FPD)
DRX-LC Detector
New
SPECT/CT Scanner
AnyScan SC

Print article
FIME - Informa

Channels

Radiography

view channel
Image: BiOI ruby-like crystals can improve medical imaging safety by lowering intensities of harmful X-rays (Photo courtesy of University of Cambridge)

Sustainable Solar Cell Material Could Revolutionize Medical Imaging

The use of X-rays for internal body imaging has dramatically changed non-invasive medical diagnostics. Yet, the high dose of X-rays required for these imaging techniques, due to the poor performance of... Read more

MRI

view channel
Image: Ezra Flash AI has received 510(k) FDA clearance, enabling roll out of the world’s first 30-minute full body MRI (Photo courtesy of Ezra)

World's First 30 Minute Full Body MRI Scan Offers Fast, Accurate and Affordable Cancer Diagnosis

A cutting-edge artificial intelligence (AI) solution enhances MR image quality, paving the way for a reduction in scan time and consequently, the cost of MRI procedures. This innovation now makes it feasible... Read more

Ultrasound

view channel
Image: Attaching microbubbles to macrophages can create high-resolution and sensitive tracking images useful for disease diagnosis (Photo courtesy of Georgia Institute of Technology)

Ultrasound Can Image Immune Cells Enhanced With Microbubbles to Diagnose Early Stage Cancer

Macrophages, a type of white blood cell, protect the human body by surrounding and consuming foreign particles such as bacteria, viruses, and dead cells. Notably, these immune cells tend to gather within... Read more

Nuclear Medicine

view channel
Image: New imaging method offers potential for diagnosing, staging, and treating multiple types of cancer (Photo courtesy of SNMMI)

New Imaging Method Superior for Diagnosing Multiple Types of Cancer

Cancer-associated fibroblasts play a significant role in tumor development, migration, and progression. A subset of these fibroblasts expresses fibroblast activation protein (FAP), a protein prominently... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The global AI-enabled medical imaging solutions market is expected to reach USD 18.36 billion in 2032 (Photo courtesy of Freepik)

Global AI-Enabled Medical Imaging Solutions Market Driven by Need for Early Disease Detection

The AI-enabled medical imaging solutions market is currently in its developmental stages, following the significant role of AI-based tools in combating the COVID-19 pandemic. The pandemic saw an upswing... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.